On January 5, 2022 Sigyn Therapeutics, Inc. (OTC Markets: "SIGY"), a medical technology company focused on the treatment of pathogen-related conditions that precipitate sepsis, reported that its Chairman and CEO, Jim Joyce, will give a corporate presentation at today’s virtual Emerging Growth Conference (Press release, Sigyn Therapeutics, JAN 5, 2022, View Source [SID1234607419]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Joyce’s presentation is scheduled to begin at 3:30pm Eastern and will be followed by questions from online participants. Please register through the following link to attend the event:

About the Emerging Growth Conference

The Emerging Growth Conference provides an interactive platform for publicly traded companies to present their endeavors to the investment community. The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.